{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T09:28:04Z","timestamp":1758274084270,"version":"3.37.3"},"reference-count":45,"publisher":"American Chemical Society (ACS)","issue":"9","license":[{"start":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T00:00:00Z","timestamp":1691366400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T00:00:00Z","timestamp":1691366400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T00:00:00Z","timestamp":1691366400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1158026"],"award-info":[{"award-number":["APP1158026"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009844","name":"PA Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009844","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001794","name":"University of Queensland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol. Pharmaceutics"],"published-print":{"date-parts":[[2023,9,4]]},"DOI":"10.1021\/acs.molpharmaceut.3c00102","type":"journal-article","created":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T14:30:30Z","timestamp":1691418630000},"page":"4468-4477","source":"Crossref","is-referenced-by-count":4,"title":["Dose-Dependent Effect of Phenothiazines as Dynamin II Inhibitors on the Uptake of PEGylated Liposomes by Endocytic Cells and In Vivo Pharmacokinetics of PEGylated Liposomal Doxorubicin in Rats"],"prefix":"10.1021","volume":"20","author":[{"given":"Christopher N.","family":"Subasic","sequence":"first","affiliation":[{"name":"School of Biomedical Sciences, The University of Queensland, St Lucia QLD 4072, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neville J.","family":"Butcher","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, The University of Queensland, St Lucia QLD 4072, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"Simpson","sequence":"additional","affiliation":[{"name":"Frazer Institute, The University of Queensland, St Lucia QLD 4072, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3178-4835","authenticated-orcid":true,"given":"Rodney F.","family":"Minchin","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, The University of Queensland, St Lucia QLD 4072, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4821-4262","authenticated-orcid":true,"given":"Lisa M.","family":"Kaminskas","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, The University of Queensland, St Lucia QLD 4072, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"316","published-online":{"date-parts":[[2023,8,7]]},"reference":[{"key":"ref1\/cit1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.019"},{"key":"ref2\/cit2","doi-asserted-by":"publisher","DOI":"10.1038\/19024"},{"key":"ref3\/cit3","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.5b00012"},{"key":"ref4\/cit4","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100365"},{"key":"ref5\/cit5","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2020.00166"},{"key":"ref6\/cit6","doi-asserted-by":"publisher","DOI":"10.1038\/nnano.2013.196"},{"key":"ref7\/cit7","doi-asserted-by":"publisher","DOI":"10.1038\/nnano.2010.250"},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.1084\/jem.190.12.1849"},{"key":"ref9\/cit9","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M207966200"},{"key":"ref10\/cit10","doi-asserted-by":"publisher","DOI":"10.18926\/AMO\/30954"},{"key":"ref11\/cit11","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-cellbio-100617-062710"},{"key":"ref12\/cit12","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a017459"},{"key":"ref13\/cit13","doi-asserted-by":"publisher","DOI":"10.1159\/000207504"},{"key":"ref14\/cit14","doi-asserted-by":"publisher","DOI":"10.1177\/1758835920985632"},{"key":"ref15\/cit15","unstructured":"Therapeutic Goods AdministrationAustralian public assessment report for bevacizumab; ACT: Australia, 2015; 1\u201353."},{"key":"ref16\/cit16","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2736(85)90521-8"},{"key":"ref17\/cit17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2019.05.043"},{"key":"ref18\/cit18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2021.07.006"},{"key":"ref19\/cit19","doi-asserted-by":"publisher","DOI":"10.1002\/jps.22682"},{"key":"ref20\/cit20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1987.tb03021.x"},{"key":"ref21\/cit21","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1365-2125.1991.tb03973.x","volume":"32","author":"Isah A. O.","year":"1991","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref22\/cit22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2013.08.004"},{"key":"ref23\/cit23","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-020-02945-2"},{"key":"ref24\/cit24","doi-asserted-by":"publisher","DOI":"10.1111\/tra.12119"},{"key":"ref25\/cit25","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-004-0825-y"},{"key":"ref26\/cit26","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2010.217"},{"key":"ref27\/cit27","doi-asserted-by":"publisher","DOI":"10.1111\/tra.12272"},{"key":"ref28\/cit28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2007.00083.x"},{"key":"ref29\/cit29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2016.04.014"},{"key":"ref30\/cit30","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-015-0102-1"},{"key":"ref31\/cit31","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02593-12"},{"key":"ref32\/cit32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2012.12.004"},{"key":"ref33\/cit33","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-010-1090-x"},{"key":"ref34\/cit34","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2021.05.009"},{"key":"ref35\/cit35","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/40.3.284"},{"key":"ref36\/cit36","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1964.03060210064021"},{"key":"ref37\/cit37","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.448"},{"key":"ref38\/cit38","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.5b00144"},{"key":"ref39\/cit39","first-page":"607","volume":"298","author":"Laverman P.","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref40\/cit40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2006.08.017"},{"key":"ref41\/cit41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2012.11.015"},{"key":"ref42\/cit42","doi-asserted-by":"publisher","DOI":"10.3109\/08982104.2012.655285"},{"key":"ref43\/cit43","doi-asserted-by":"publisher","DOI":"10.1211\/jpp.60.12.0011"},{"key":"ref44\/cit44","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.2c04543"},{"key":"ref45\/cit45","doi-asserted-by":"publisher","DOI":"10.7150\/thno.22164"}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.3c00102","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.3c00102","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T16:15:43Z","timestamp":1702916143000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acs.molpharmaceut.3c00102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,7]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9,4]]}},"alternative-id":["10.1021\/acs.molpharmaceut.3c00102"],"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.3c00102","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"type":"print","value":"1543-8384"},{"type":"electronic","value":"1543-8392"}],"subject":[],"published":{"date-parts":[[2023,8,7]]}}}